Safety, Tolerability and Pharmacokinetic Study of MT-3995 in Subjects With Diabetic Nephropathy
Clinical trial NCT01889277 · COMPLETED
Trial details
- NCT number
- NCT01889277
- Sponsor
- Tanabe Pharma Corporation
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-01
- Primary completion
- 2015-01-01
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.